Found: 8
Select item for more details and to access through your institution.
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4518, doi. 10.3390/cancers13184518
- By:
- Publication type:
- Article
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06453-6
- By:
- Publication type:
- Article
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.619069
- By:
- Publication type:
- Article
The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01610-0
- By:
- Publication type:
- Article
The B-Side of Cancer Immunity: The Underrated Tune.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 449, doi. 10.3390/cells8050449
- By:
- Publication type:
- Article
Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia.
- Published in:
- Cancer Communications, 2023, v. 43, n. 12, p. 1373, doi. 10.1002/cac2.12493
- By:
- Publication type:
- Article
Diagnostic and Therapeutic Potential of Extracellular Vesicles in B-Cell Malignancies.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.580874
- By:
- Publication type:
- Article